期刊
BREAST CANCER RESEARCH AND TREATMENT
卷 173, 期 2, 页码 455-463出版社
SPRINGER
DOI: 10.1007/s10549-018-4990-9
关键词
Pathologic complete response; Neoadjuvant therapy; Breast cancer; Breast cancer MRI; MRI radiomics; Machine learning; Logistic regression; Support vector machines
类别
资金
- North Carolina Biotechnology Center [2016-BIG-6520]
- National Institutes of Health [1R01EB021360]
PurposeTo determine whether a multivariate machine learning-based model using computer-extracted features of pre-treatment dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can predict pathologic complete response (pCR) to neoadjuvant therapy (NAT) in breast cancer patients.MethodsInstitutional review board approval was obtained for this retrospective study of 288 breast cancer patients at our institution who received NAT and had a pre-treatment breast MRI. A comprehensive set of 529 radiomic features was extracted from each patient's pre-treatment MRI. The patients were divided into equal groups to form a training set and an independent test set. Two multivariate machine learning models (logistic regression and a support vector machine) based on imaging features were trained to predict pCR in (a) all patients with NAT, (b) patients with neoadjuvant chemotherapy (NACT), and (c) triple-negative or human epidermal growth factor receptor 2-positive (TN/HER2+) patients who had NAT. The multivariate models were tested using the independent test set, and the area under the receiver operating characteristics (ROC) curve (AUC) was calculated.ResultsOut of the 288 patients, 64 achieved pCR. The AUC values for predicting pCR in TN/HER+ patients who received NAT were significant (0.707, 95% CI 0.582-0.833, p<0.002).ConclusionsThe multivariate models based on pre-treatment MRI features were able to predict pCR in TN/HER2+ patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据